Detalhe da pesquisa
1.
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
BJOG
; 131(6): 848-857, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752678
2.
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
Am J Obstet Gynecol
; 229(4): 388-409.e4, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059410
3.
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods Manual.
Value Health
; 26(10): 1503-1509, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268059
4.
Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study.
J Med Genet
; 59(2): 122-132, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568437
5.
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes.
BJOG
; 129(12): 1970-1980, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781768
6.
Cost-Utility Analysis of a Complex Intervention to Reduce School-Based Bullying and Aggression: An Analysis of the Inclusive RCT.
Value Health
; 24(1): 129-135, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431147
7.
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.
Int J Gynecol Cancer
; 31(2): 286-291, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907814
8.
Costs of Early Invasive Breast Cancer in England Using National Patient-Level Data.
Value Health
; 23(10): 1316-1323, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032775
9.
Cost-effectiveness of breast cancer screening programme for women in rural China.
Int J Cancer
; 144(10): 2596-2604, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367451
10.
Effects of the Learning Together intervention on bullying and aggression in English secondary schools (INCLUSIVE): a cluster randomised controlled trial.
Lancet
; 392(10163): 2452-2464, 2018 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30473366
11.
Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: response.
Am J Obstet Gynecol
; 230(2): 274-275, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659746
12.
Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population.
J Med Genet
; 55(8): 538-545, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622727
13.
Economic burden of HIV and TB/HIV coinfection in a middle-income country: a costing analysis alongside a pragmatic clinical trial in Brazil.
Sex Transm Infect
; 94(6): 463-469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545471
14.
Cost-effectiveness of risk-based breast cancer screening programme, China.
Bull World Health Organ
; 96(8): 568-577, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104797
15.
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.
Am J Obstet Gynecol
; 218(4): 431.e1-431.e12, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288066
16.
Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review.
Value Health
; 21(4): 482-490, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29680106
17.
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Am J Obstet Gynecol
; 217(5): 578.e1-578.e12, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28690137
18.
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis.
J Med Genet
; 53(9): 591-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354448
19.
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.
J Med Genet
; 53(7): 472-80, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26993268
20.
Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?
Health Econ
; 25 Suppl 1: 29-41, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26775571